Table 3.
DRA-OPAT Participants by Program Completion
| Cohort | Completed DRA-OPAT | Did Not Complete Program |
|---|---|---|
| N | 16 | 19 |
| Age, years (median, IQI) | 35 (28–53.3) | 40 (34–49) |
| Male, N (%) | 9 (56.3) | 10 (52.6) |
| Race, non-white | 1 (6.3) | 5 (26.3) |
| Cocaine use | 1 (6.3) | 1 (5.3) |
| Opioid use | 15 (93.8) | 13 (68.4) |
| Polysubstance use | 8 (50) | 14 (73.7) |
| Stimulant use | 8 (50) | 15 (78.9) |
| Medication for opioid use disordera | 14 (87.5) | 8 (42.1) |
| Homelessa | 12 (75) | 8 (42.1) |
| Insured | 1 (6.3) | 6 (31.6) |
| Charlson comorbidity index | 32 (12.5) | 20 (12–33) |
| HIV | 0 (0) | 0 (0) |
| Hepatitis C | 4 (25) | 5 (26.3) |
| Cerebrovascular disease | 1 (6.3) | 2 (10.5) |
| Congestive heart failure | 0 (0) | 4 (21.1) |
| Diabetes mellitus | 2 (12.5) | 5 (26.3) |
| Hepatic disease | 5 (31.3) | 7 (36.8) |
| Chronic pulmonary disease | 6 (37.5) | 6 (31.6) |
| Kidney disease | 2 (12.5) | 2 (10.5) |
| Endocarditis | 7 (43.8) | 7 (36.8) |
| Osteoarticular infection | 6 (37.5) | 8 (42.1) |
| Skin/soft tissue infection | 12 (75) | 8 (42.1) |
| Vertebral abscess/discitis/osteomyelitis | 6 (37.5) | 4 (21.1) |
| Staphylococcus aureus bacteremia | 8 (50) | 9 (47.4) |
| Bone or joint debridement | 7 (43.8) | 5 (26.3) |
| Cardiac valve replacement | 0 (0) | 0 (0) |
| Soft tissue debridement | 6 (37.5) | 7 (36.8) |
| Spinal debridement | 2 (12.5) | 1 (5.3) |
| Hospital length of stay, days (median, IQI)a | 13.5 (10.6–18.5) | 9.1 (7.7–13.4) |
| Days at program facilitya | 24 (19.5–38) | 4 (2–9) |
| 30-day readmission | 2 (12.5) | 2 (10.5) |
| 90-day readmission | 5 (31.3) | 4 (21.1) |
| Mortality, 30-day all-cause | 0 (0) | 0 (0) |
| Mortality, 1-year | 0 (0) | 0 (0) |
| Positive toxicology screen during program | 0 (0) | 2 (10.5) |
| PICC line abuse | 0 (0) | 2 (10.5) |
| Adverse event during program treatment | 3 (18.8) | 4 (21.1) |
Abbreviations: DRA-OPAT, drug recovery assistance and parenteral antibiotic therapy; HIV, human immunodeficiency virus; IQI, 25%–75% interquartile interval; PICC, peripherally inserted central venous catheter.
Significant at P < .05.